Financials GelStat Corp.

Equities

GSAC

US3685331056

Pharmaceuticals

Market Closed - OTC Markets 15:01:05 2024-05-31 EDT 5-day change 1st Jan Change
0.0004 USD -.--% Intraday chart for GelStat Corp. -.--% +33.33%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023
Capitalization 1 0.75 1.95 5.841 0.5884 0.543
Enterprise Value (EV) 1 0.7488 2.146 6.03 0.9498 1.102
P/E ratio -125 x -11 x -12 x -0.74 x -1.86 x
Yield - - - - -
Capitalization / Revenue - 493,664,304 x 831,750,641 x 252,190,742 x 3,631,197 x
EV / Revenue - 543,344,810 x 858,660,496 x 407,113,588 x 7,367,338 x
EV / EBITDA - - - - -7,303,838 x
EV / FCF - -32,347,802 x -31,326,545 x 49,543,373 x -14,453,489 x
FCF Yield - -0% -0% 0% -0%
Price to Book -29.4 x -9.58 x -18.9 x -0.88 x -0.7 x
Nbr of stocks (in thousands) 499,994 499,994 524,994 653,735 1,809,875
Reference price 2 0.001500 0.003900 0.0111 0.000900 0.000300
Announcement Date 10/29/21 10/29/21 5/2/22 5/10/23 5/7/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023
Net sales - 0.00395 0.007022 0.002333 0.1495
EBITDA - - - - -0.1508
EBIT 1 -0.00622 -0.1775 -0.3133 -0.603 -0.1658
Operating Margin - -4,494.86% -4,461.83% -25,846.38% -110.9%
Earnings before Tax (EBT) 1 -0.00622 -0.1778 -0.4752 -0.7612 -0.2066
Net income 1 -0.00622 -0.1778 -0.4752 -0.7612 -0.2101
Net margin - -4,502.23% -6,767.92% -32,626.88% -140.52%
EPS 2 -0.000012 -0.000355 -0.000926 -0.001224 -0.000161
Free Cash Flow - -0.0663 -0.1925 0.0192 -0.0762
FCF margin - -1,679.7% -2,741% 821.73% -50.97%
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 10/29/21 10/29/21 5/2/22 5/10/23 5/7/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023
Net Debt 1 - 0.2 0.19 0.36 0.56
Net Cash position 1 0 - - - -
Leverage (Debt/EBITDA) - - - - -3.704 x
Free Cash Flow - -0.07 -0.19 0.02 -0.08
ROE (net income / shareholders' equity) - 155% 178% 147% 27.8%
ROA (Net income/ Total Assets) - -157% -122% -375% -101%
Assets 1 - 0.1133 0.3911 0.2029 0.2075
Book Value Per Share 2 -0 -0 -0 -0 -0
Cash Flow per Share 2 0 0 0 0 0
Capex - - - - -
Capex / Sales - - - - -
Announcement Date 10/29/21 10/29/21 5/2/22 5/10/23 5/7/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. GSAC Stock
  4. Financials GelStat Corp.